amrinone has been researched along with Coronary Vessel Anomalies in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Coronary Vessel Anomalies: Malformations of CORONARY VESSELS, either arteries or veins. Included are anomalous origins of coronary arteries; ARTERIOVENOUS FISTULA; CORONARY ANEURYSM; MYOCARDIAL BRIDGING; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulloa Santamaría, E | 1 |
| Pérez Navero, JL | 1 |
| Velasco Jabalquinto, MJ | 1 |
| Ibarra de la Rosa, I | 1 |
| Suanes Cabello, A | 1 |
| Martínez Alarcón, J | 1 |
| Barcones Mingueza, F | 1 |
1 other study available for amrinone and Coronary Vessel Anomalies
| Article | Year |
|---|---|
[Combined use of amrinone and dobutamine in the postoperative period following cardiovascular surgery].
Topics: Amrinone; Cardiac Surgical Procedures; Coronary Vessel Anomalies; Dobutamine; Drug Therapy, Combinat | 1991 |